Trial
NCT04375514
Study of ARO-ENaC in Healthy Volunteers and in Patients With Cystic Fibrosis
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Arrowhead Pharmaceuticals
Collaborators
—
Condition
Cystic Fibrosis, Pulmonary
Intervention
ARO-ENaC
Why stopped
Business decision
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-12-17